Skip to main content

Table 1 List of the drugs that were most effective in inhibiting EMT in the mesenchymal MDA-MB 231 reporter cells and their reported targets

From: GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer

 

Drug

Target

1

TSU-68 (orantinib)

VEGFR, PDGFR, FGFR

2

Rocilinostat (ACY-1215)

HDAC

3

Trichostatin A (TSA)

HDAC

4

CUDC-101

HDAC, HER2, EGFR

5

PD168393

EGFR

6

SCH79797

Par1 antagonist

7

CP-673451

PDGFR

8

Panobinostat (LBH589)

HDAC

9

BIO

GSK3

10

Cabozantinib malate

VEGFR, Axl

11

GW9662

PPAR